Lisata Therapeutics
LSTA | NASDAQ
$1.09
-$0.12 (-9.92%)
At close: Nov 16, 2026, 4:00 PM ET
$1.10
+$0.01 (+0.94%)
After-hours:
Nov 16, 2026, 5:56 PM ET
-9.92%
(1D)No price chart data available for 1D timeframe.
Rating
43.2
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #438/1021 (Top 43%)
Key Statistics
Market Data
Market Cap $9.82M
1D Range
1.04 1.22
52W Range
0.99 5.04
Valuation (TTM)
PE -0.58
PB 1.29
EV/EBITDA N/A
Valuation (NTM)
Forward PE N/A
Forward PEG 0.01
Price Target $0.00
Cash Flow
FCF Yield -220.6%
SBC Adj. FCF Yield -234.3%
SBC Impact -6.3%
Margins
Gross Margin 91.0%
Operating Margin -22043.0%
FCF Margin -21662.0%
Growth (CAGR)
Revenue 3Y | 5Y 12.8% |
54.3%
Dil EPS 3Y | 5Y 14.5% |
49.6%
FCF 3Y | 5Y -7.2% |
0.6%
Returns
ROA -2.6%
ROE -164.7%
ROIC -2.5%
Financial Health
Net Cash
$281.84M
Current Ratio 14.09
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Lisata Therapeutics, Inc. is a clinical-stage biopharmaceutical firm focused on pioneering and bringing to market cellular therapies. These treatments are designed to either reverse disease progressio...
Sector Healthcare
Industry Biotechnology
Employees 21
IPO Date Mar 1, 1999
Website www.lisata.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove LSTA